Fluorescent oligonucleotides can serve as suitable alternatives to radiolabeled oligonucleotides

Journal of Biomolecular Techniques

Volumn 20, Issue 4, 2009, Pages 190-194

  Ballal, Rahul ^a   Cheema, Amrita ^a   Ahmad, Waaqar ^a   Rosen, Eliot M ^a   Saha, Tapas ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

FITC; Fluorescence; Incision assay; OGG1; Radioactivity

Indexed keywords

8 HYDROXYGUANINE; FLUORESCEIN ISOTHIOCYANATE; OLIGONUCLEOTIDE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE OGG1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL LYSATE; CONTROLLED STUDY; DNA REPAIR; FLUORESCENCE; HUMAN; HUMAN CELL; ISOTOPE LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; RADIOACTIVITY; STEREOSPECIFICITY;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL LINE, TUMOR; DEOXYGUANOSINE; DNA GLYCOSYLASES; DNA REPAIR; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GENES, BRCA1; HUMANS; ISOTOPE LABELING; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDE PROBES; RADIOISOTOPES; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

EID: 77953669871     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Maier J, Schott K, Werner T, Bacher A, Ziegler I. Northern blot analysis of sepiapterin reductase mRNA in mammalian cell lines and tissues. Adv Exp Med Biol 1993;338:195-198.
2. Wolf SS, Hopley JG, Schweizer M. The application of 33P-labeling in the electrophoretic mobility shift assay. Biotechniques 1997;16:590-592.
3. Hill JW, Evans MK. A novel R229Q OGG1 polymorphism results in a thermolabile enzyme that sensitizes KG-1 leukemia cells to DNA damaging agents. Cancer Detect Prev 2007;31:237-243.
4. Cistulli CA, Sorger T, Marsella JM, Vaslet CA, Kane AB. Spontaneous p53 mutation in murine mesothelial cells: increased sensitivity to DNA damage induced by asbestos and ionizing radiation. Toxicol Appl Pharmacol 1996;141:264-271.
5. Kote-Jarai Z, Williams RD, Cattini N, et al. Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier status. Clin Cancer Res 2004;10:958-963.
6. Fan S, Meng Q, Auborn K, Carter T, Rosen EM. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 2006;94:407-426.
7. Fan S, Wang, JA, Yuan RQ, et al. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene 1998;16:3069-3082.
8. Saha T, Ghosh S, Vassilev A, DePamphilis ML. Ubiquitylation, phosphorylation and Orc2 modulate the subcellular location of Orc1 and prevent it from inducing apoptosis. J Cell Sci 2006;119:1371-1382.
9. Saha T, Vardhini D, Tang Y. RING finger-dependent ubiquitination by PRAJA is dependent on TGF-β and potentially defines the functional status of the tumor suppressor ELF. Oncogene 2006;25:693-705.
10. Adhikari S, Toretsky JA, Yuan L, Roy R. Magnesium, essential for base excision repair enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase. J Biol Chem 2006;281:29525-29532.
11. Nyaga SG, Lohani A, Jaruga P, Trzeciak AR, Dizdaroglu M, Evans MK. Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937. BMC Cancer 2006;6:297.
12. Trzeciak AR, Nyaga SG, Jaruga P, Lohani A, Dizdaroglu M, Evans MK. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis 2004;25:1359-1370.
13. Yacoub A, Kelley MR, Deutsch WA. The DNA repair activity of human redox/repair protein APE/Ref-1 is inactivated by phosphorylation. Cancer Res 1997;57:5457-5459.
14. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
15. Hazra TK, Izumi T, Boldogh I. Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA. Proc Natl Acad Sci USA 2002;99:3523-3528.
16. Hazra TK, Izumi T, Venkataraman R, Kow YW, Dizdaroglu M, Mitra S. Characterization of a novel 8-oxoguanine-DNA glycosylase activity in Escherichia coli and identification of the enzyme as endonuclease VIII. J Biol Chem 2000;275:27762-27767.
17. Karahalil B, de Souza-Pinto NC, Parsons JL, Elder RH, Bohr VA. Compromised incision of oxidized pyrimidines in liver mitochondria of mice deficient in NTH1 and OGG1 glycosylases. J Biol Chem 2003;278:33701- 33707.
18. Miki Y, Swensen J, Shattuck-Eidens D. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
19. Boulton SJ. BRCA1-mediated ubiquitylation. Cell Cycle 2006;5:1481-1486.
20. Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006;34:1416-1426.
21. Kobayashi J, Antoccia A, Tauchi H, Matsuura S, Komatsu K. NBS1 and its functional role in the DNA damage response. DNA Repair (Amst) 2004;3:855-861.
22. Monteiro AN. BRCA1: exploring the links to transcription. Trends Biochem Sci 2000;25:469-474.
23. Rosen EM, Fan S, Ma Y. BRCA1 regulation of transcription. Cancer Lett 2006;236:175-185.
24. Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003;196:19-41.
25. Yarden RI, Papa MZ. BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions. Mol Cancer Ther 2006;5:1396-1404.
26. Yu V. Caretaker Brca1: keeping the genome in the straight and narrow. Breast Cancer Res 2000;2:82-85.
27. Bankier AT. Dideoxy sequencing reactions using Klenow fragment DNA polymerase 1. Methods Mol Biol 1993;23:83-90.
28. Jones GD, Dickinson L, Lunec J, Routledge MN. SVPD-postlabeling detection of oxidative damage negates the problem of adventitious oxidative effects during 32P-labeling. Carcinogenesis 1999;20:503-507.